Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study

Dan Nordström, Ann Knight, Reijo Luukkainen, Ronald van Vollenhoven, Vappu Rantalaiho, ANNA KAJALAINEN, Johan G. Brun, Anne Prøven, Lotta Ljung, Hannu Kautiainen,

The Journal of Rheumatology · 2012 · 159 citations · 12 references

DOIFull text

Open access

Abstract

Anakinra induced more beneficial responses than DMARD in patients with AOSD and was favored in the OLE phase. (ClinicalTrials.gov Protocol Registration NCT01033656).

References

12